Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study

This multicentre phase II study was aimed at investigating the activity and safety of pegylated liposomal doxorubicin (PLD) and gemcitabine (GEM) as front-line therapy in a large series of chemotherapy-naïve recurrent/metastatic breast cancer patients. From June 2003 to December 2006, a total of 71...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Adamo, V, Lorusso, V, Rossello, R, Adamo, B, Ferraro, G, Lorusso, D, Condemi, G, Priolo, D, Di Lullo, L, Paglia, A, Pisconti, S, Scambia, G, Ferrandina, G
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2008
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2441953/
https://ncbi.nlm.nih.gov/pubmed/18493232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604409
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi